Goldman Sachs’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $511K | Sell |
207,008
-44,391
| -18% | -$110K | ﹤0.01% | 4249 |
|
|
2025
Q1 | $500K | Sell |
251,399
-170,499
| -40% | -$339K | ﹤0.01% | 4251 |
|
|
2024
Q4 | $1.23M | Buy |
421,898
+201,754
| +92% | +$589K | ﹤0.01% | 3784 |
|
|
2024
Q3 | $852K | Buy |
220,144
+140,777
| +177% | +$545K | ﹤0.01% | 3844 |
|
|
2024
Q2 | $408K | Buy |
79,367
+41,187
| +108% | +$212K | ﹤0.01% | 4053 |
|
|
2024
Q1 | $267K | Sell |
38,180
-12,969
| -25% | -$90.8K | ﹤0.01% | 4243 |
|
|
2023
Q4 | $453K | Sell |
51,149
-7,762
| -13% | -$68.8K | ﹤0.01% | 4007 |
|
|
2023
Q3 | $562K | Buy |
+58,911
| New | +$562K | ﹤0.01% | 3845 |
|